Open Label Study Telmisartan and Amlodipine in Hypertension
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to assess the efficacy and safety of the fixed dose
combinations telmisartan 40 mg / amlodipine 5 mg (T40/A5) or telmisartan 80 mg / amlodipine 5
mg (T80/A5) during long-term open-label treatment.